13F HOLDINGS REPORT
ENAVATE SCIENCES GP, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001415889-25-021852
Total Value
$176.5M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IMMUNOME INC | IMNM | 4,768,583 | $44.3M | 25.12% |
| 2 | SIONNA THERAPEUTICS INC | SION | 2,478,030 | $43.0M | 24.35% |
| 3 | ZENAS BIOPHARMA INC | ZBIO | 3,761,359 | $36.4M | 20.65% |
| 4 | UPSTREAM BIO INC | UPB | 2,459,703 | $27.0M | 15.30% |
| 5 | COMPASS THERAPEUTICS INC | CMPX | 7,788,150 | $20.2M | 11.47% |
| 6 | CAMP4 THERAPEUTICS CORP | CAMP | 3,785,802 | $5.5M | 3.11% |